Why the study?
Simple tools to predict outcomes in pulmonary hypertension are lacking, and the association of heart rate variability and heart rhythm complexity with pulmonary hypertension mortality remains unclear.
Do heart rate variability and heart rhythm complexity metrics predict long-term mortality in patients with pulmonary hypertension?
Cohort (n=74)
No
Do heart rate variability and heart rhythm complexity metrics predict long-term mortality in patients with pulmonary hypertension?
p-value: p=<0.001
Combining heart rate variability and heart rhythm complexity metrics provides a non-invasive tool to predict long-term mortality in patients with pulmonary hypertension.
Pulmonary hypertension (PH) is a serious disease, however simple tools to predict outcomes are lacking. In our previous investigation, we found that heart rate variability (HRV) and heart rhythm complexity (HRC) were associated with the detection and severity of PH, however their association with PH mortality remains unclear. The aim of this study was to investigate these metrics as a tool for determining long-term outcomes in PH patients. We enrolled 74 Asian PH patients with WHO PH group 1 or 4 at a single hospital in Taiwan between March 2012 and June 2018. After a median follow-up duration of 58 months (to January 2023), 22 patients had died. The patients who died had a significantly lower lean body mass index (BMI), impaired renal function, higher N-terminal pro B-type natriuretic peptide (NT-proBNP) level, lower very low-frequency (VLF), lower short-term detrended fluctuation analysis α1 (DFAα1), and lower multiscale entropy scale 5 value. In multivariable analysis, BMI, VLF and multiscale entropy scale 5 were significantly associated with survival. The best cut-off VLF and scale 5 values were 115.13 and 0.738, respectively. We then categorized the study population into three groups: both elevated VLF/scale 5 (group 1), either depressed VLF or depressed scale 5 (group 2), and both depressed VLF/scale 5 (group 3). The results showed that group 1 had the best outcomes, whereas group 3 had the worst survival (P < 0.001). Combining HRV and HRC metrics appears to be a good non-invasive tool to predict the long-term outcomes of patients with PH.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2024) conducted a cohort in Pulmonary hypertension (n=74). Heart rate variability and heart rhythm complexity (VLF and multiscale entropy scale 5) vs. Elevated VLF and scale 5 was evaluated on Survival (p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: